ArticleDie Ophthalmologie2026
[Amniotic membrane transplantation in various systemic diseases : Success and recurrence rates in relation to concomitant systemic medication, corneal status, and surgical technique].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmniotic membrane transplantation (AMT) has been an important procedure for treatment of persistent corneal epithelial defects for many years. The aim of this study was to evaluate the influence of underlying systemic diseases, concomitant systemic medication, corneal status, depth of the epithelial defect, and surgical technique on AMT success and recurrence rates. PATIENTS AND
methodsA total of 780 AMT procedures (496 patients, 519 eyes) performed from 2013 to 2019 were retrospectively analyzed. The presence of systemic disease (divided into different categories) and concomitant medication, the depth of the corneal defect (erosion/ulcer), the corneal status (own cornea/graft), and the surgical technique (patch/sandwich/graft) were recorded. Main outcome measures included epithelial closure at 4 weeks ("success") and the recurrence rate. The follow-up period was 1 year. Significance was set at p ≤ 0.05.
resultsThere was an epithelial closure rate of 58.8% and a recurrence rate of 18.7%. Cases with thyroid gland disease had a significantly lower success rate than the rest of the study population (p = 0.003). Cases with a viral infection showed a significantly higher success rate (65.7%, n = 204) compared to cases without a viral etiology (56.5%, n = 326; p = 0.039). Regarding concomitant medication, the success rate was significantly higher when systemic steroids were used (p < 0.001). Comparing the success of AMT on the own cornea and on a graft, the success rate on the own cornea was significantly higher (p = 0.019) than on a donor cornea. There was no significant difference in surgical technique regarding success and recurrence rate.
conclusionAmniotic membrane transplantation is a reasonable option for persistent epithelial defects even under everyday clinical conditions. Especially in case of primary success (epithelial closure after 4 weeks) can a better long-term outcome be assumed. Thyroid gland disease is related to significantly worse success rates. Significantly worse results of AMT can be expected on a transplant than on the patient's own cornea.
Indexed as
Identifiers
42053611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.